Y-mAbs Provides Regulatory Update on Omburtamab 20 April 2021
Press Release NEW YORK, April 20, 2021 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company”... Read more
Press Release NEW YORK, April 20, 2021 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company”... Read more
Press Release BERLIN, Germany, April 14, 2021 – LINK Medical, the Northern European clinical research... Read more
Press Release NEW YORK, April 12, 2021 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company”... Read more
We are excited to share with you EBD’ new products and initiatives that are being launched this month. Startup... Read more
Press Release 2cureX announced today that its prospective interventional clinical trial investigating... Read more
Press Release NEW YORK, Feb. 25, 2021 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company”... Read more
Press Release NEW YORK, Feb. 22, 2021 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company”... Read more
PRESS RELEASE In this collaboration Almirall will commercialize Wynzora® Cream for treatment of plaque... Read more
PRESS RELEASE NEW YORK, Feb. 16, 2021 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company”... Read more